United States - English - NLM (National Library of Medicine)

general injectables and vaccines, inc - haloperidol lactate (unii: 6387s86pk3) (haloperidol - unii:j6292f8l3d) - haloperidol 5 mg in 1 ml - haloperidol injection is indicated for use in the treatment of schizophrenia. haloperidol injections is indicated for the control of tics and vocal utterances of tourette's disorder. haloperidol injection is contraindicated in sever toxic central nervous system depression or comatose states from any cause and in individuals who are hypersensitive to this drug or have parkinson's disease.

Malta - English - Medicines Authority

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - haloperidol - oral solution - haloperidol 1 mg/ml - psycholeptics

Malta - English - Medicines Authority

crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - haloperidol - tablet - haloperidol 0.5 mg - psycholeptics

Malta - English - Medicines Authority

crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - haloperidol - tablet - haloperidol 1.5 mg - psycholeptics

Canada - English - Health Canada

sandoz canada incorporated - haloperidol (haloperidol decanoate) - liquid - 50mg - haloperidol (haloperidol decanoate) 50mg - butyrophenones

Canada - English - Health Canada

sandoz canada incorporated - haloperidol (haloperidol decanoate) - liquid - 100mg - haloperidol (haloperidol decanoate) 100mg - butyrophenones

Ireland - English - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - haloperidol - solution for injection - 5 milligram(s)/millilitre - butyrophenone derivatives; haloperidol

Canada - English - Health Canada

sandoz canada incorporated - haloperidol - liquid - 5mg - haloperidol 5mg - butyrophenones

Canada - English - Health Canada

omega laboratories limited - haloperidol - solution - 5mg - haloperidol 5mg - butyrophenones

United States - English - NLM (National Library of Medicine)

tya pharmaceuticals - haloperidol (unii: j6292f8l3d) (haloperidol - unii:j6292f8l3d) - haloperidol 2 mg - haloperidol tablets are indicated for use in the management of manifestations of psychotic disorders. haloperidol tablets are indicated for the control of tics and vocal utterances of tourette’s disorder in children and adults. haloperidol tablets are effective for the treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation). haloperidol tablets are also effective in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. haloperidol tablets should be reserved for these two groups of children only after failure to respond to psychotherapy or medications other than antipsychotics. haloperidol tablets are contraindicated in severe toxic central nervous system depression or comatose states from any caus